Editor in Chief and Section Editors
Luca Pani, MD is Professor of Pharmacology and Clinical Pharmacology at the Department of Biomedical, Metabolic and Neural Sciences of the University of Modena and Reggio Emilia, in Modena Italy and Professor of Clinical Psychiatry at the Department of Psychiatry and Behavioral Sciences, University of Miami. Luca is the VP for Regulatory Strategy and Market Access Innovation at VeraSci, Durham, NC, USA (previously known as NeuroCog Trials) and the Chief Scientific Officer of EDRA Publishing Company, Milan Italy and of Inpeco SA Total Lab Automation, Novazzano Switzerland. As the former Director General of the Italian Medicines Agency (AIFA, 2011-2016) and former member of the CHMP and SAWP for EMA in London (2010-2017), he is a recognized expert in psychopharmacology, clinical psychiatry and regulatory science with particular emphasis on health technology assessment linked with novel negotiation strategies for the reimbursement of precision medicines.
Elisabetta Cerbai is professor at the Department of Neuroscienze, Area del Farmaco e Salute del Bambino at University of Florence.
Claes Wahlestedt, is a Swedish-American biomedical researcher and entrepreneur. He’s professor at the University of Miami.
Gilberto Corbellini is Professor of History of Medicine and Professor of Bioethics at the University of Rome – Sapienza.
Pharmadvances Honorary Advisory Board
Marzia Del Re
Giorgio Cantelli Forti
Annamaria De Luca
Giovambattista De Sarro
Maria Angela Sortino
Monica Di Luca, SIF
Chairman of the Management Committee
Ludovico Baldessin, Edra
Alessandro Mugelli, SIF
Giorgio Racagni, SIF